OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST
Takayasu Mishima, Shih‐Wei Chiu, Hidemoto Saiki, et al.
Journal of the Neurological Sciences (2023) Vol. 448, pp. 120619-120619
Closed Access | Times Cited: 5
Takayasu Mishima, Shih‐Wei Chiu, Hidemoto Saiki, et al.
Journal of the Neurological Sciences (2023) Vol. 448, pp. 120619-120619
Closed Access | Times Cited: 5
Showing 5 citing articles:
Comparative Safety of Istradefylline in Parkinson's Disease: A Systematic Review of Randomized Controlled Trials and Real-World Studies
Joyce Qian, Sagari Betté, Hannah Cummings, et al.
(2025)
Closed Access
Joyce Qian, Sagari Betté, Hannah Cummings, et al.
(2025)
Closed Access
Comparative safety of istradefylline in Parkinson’s disease: A systematic review of randomized controlled trials and real-world studies
Sagari Betté, Joyce Qian, Hannah Cummings, et al.
Clinical Parkinsonism & Related Disorders (2025) Vol. 12, pp. 100307-100307
Open Access
Sagari Betté, Joyce Qian, Hannah Cummings, et al.
Clinical Parkinsonism & Related Disorders (2025) Vol. 12, pp. 100307-100307
Open Access
Ginsenoside Rg1 in Parkinson’s disease: from basic research to clinical applications
Qianyan Wang, Wei Lei, Guang‐Hui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Qianyan Wang, Wei Lei, Guang‐Hui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Levodopa‐Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5‐Year Follow‐Up Study
Diego Santos‐García, Teresa de Deus, Carlos Cores, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 7, pp. 830-849
Closed Access | Times Cited: 1
Diego Santos‐García, Teresa de Deus, Carlos Cores, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 7, pp. 830-849
Closed Access | Times Cited: 1
Prescription trends in Japanese advanced Parkinson’s disease patients with non-motor symptoms: J-FIRST
Masahiro Nomoto, Yoshio Tsuboi, Kenichi Kashihara, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0309297-e0309297
Open Access
Masahiro Nomoto, Yoshio Tsuboi, Kenichi Kashihara, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0309297-e0309297
Open Access
